HOME >> MEDICINE >> NEWS
Comparison of patients' access to new and better cancer drugs reveals inequalities between countries

er drugs with improved patient survival. Dr Wilking said: "Nearly half of the observed improvement in the two-year cancer survival rate between 1992 and 2000 at 50 USA cancer centres could be attributed to the use of newer cancer drugs. In 20 countries, including the USA and Europe, between 1995 and 2003, nearly a third of the reduction in cancer deaths could be accounted for by the use of newer drugs."

The authors called for action to end the inequalities. "It is our hope that this report will inspire policy makers and decision makers to take action to address these imbalances so that access to new innovative cancer drugs does not become dependent on the patient's country of residence," they said.

They pointed out that although cancer was second or third in terms of disease burden in most countries, the share of health care expenditure allocated to it was significantly lower than the share of the burden of the disease.

Dr Jnsson said: "Cancer accounts for about 5-6% of all health care expenditure and cancer drugs account for between 10-20% of this expenditure and just 5% of all drug costs. But cancer research continues to grow, with many new drugs and treatments expected to be introduced in the coming years. Countries need to address urgently how they are going to accommodate newer drugs into health care systems and pay for them."

Economic evaluation of new drugs and their cost effectiveness were becoming increasingly important, the authors said, with Europe and the UK in particular playing a leading role in the production of health technology assessments. In the UK these are produced by the National Institute for Health and Clinical Excellence (NICE). "It was the explicit objective at the establishment of NICE to avoid any significant delays to bringing innovations to market in the UK. There is yet no evidence that this objective is met," they report.

The report also highlights an imbalance in public investments
'"/>

Contact: Emma Mason
wordmason@mac.com
44-077-112-96986
European Society for Medical Oncology
9-May-2007


Page: 1 2 3 4

Related medicine news :

1. Comparison of obstetric outcomes between on-call and patients own obstetricians
2. Comparison of 4 diet plans shows better outcomes for diet with lowest carbohydrate intake
3. Comparison of drug-releasing coronary stents show similar effectiveness
4. Hepatitis B patients understanding of infection and treatment deficient
5. Alzheimers weight gain initiative also improved patients intellectual abilities
6. Referral management schemes damage patients interests
7. Blood transfusions raise heart patients infection and death risk -- especially women
8. New UF tool measures heart implant patients anxiety
9. New research addresses taboos around the impact of rheumatoid arthritis on patients sex lives
10. Secret herb in tests to stop breast cancer patients hot flushes and night sweats
11. Internet research builds cancer patients confidence

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that ... insurance companies have a waiver for care if the client has a cognitive impairment ... family pays for care, is often waived, so the benefits from their insurance start ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released a ... books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture of ... have tossed it off as mere rubbish, but Yisrayl Hawkins says that is because ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the ... published author, William Nowers. Captain Nowers and his wife, Millie, have six children, ... in the Navy. Following his career as a naval aviator and carrier pilot, ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... AVACEN Medical , Inc. (AVACEN) announced that Frost & ... Innovation Award for Its fibromyalgia pain management device. The ... market research by Frost & Sullivan,s industry experts. ... product, the AVACEN 100, offers a safe and effective solution ... ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ... on fulfilling the promise of precision medicine, today announced ... joined Caris, Precision Oncology Alliance™ (POA) as its 17 ... centers, the St. Jude Crosson Cancer Institute will help ... the use of tumor profiling, making cancer treatment more ...
(Date:10/10/2017)... , Oct. 10, 2017   West Pharmaceutical Services, ... solutions for injectable drug administration, today shared the results ... Adapter for improving the intradermal administration of polio vaccines. ... Vaccination Summit in May 2017 by Dr. Ondrej ... Department, World Health Organization (WHO), and recently published in ...
Breaking Medicine Technology:
Cached News: